Disease | vaccinia |
Phenotype | C0025202|melanoma |
Sentences | 2 |
PubMedID- 24829758 | We have identified ilt2 as a potential biomarker of clinical response in melanoma patients treated with oncolytic vaccinia virus immunotherapy. |
PubMedID- 23833682 | The uniqueness of our immunotherapeutic vaccine arises from infecting primary melanoma cells with live vaccinia virus, which acts as a natural adjuvant. |
Page: 1